Cargando…

Major reduction of NKT cells in patients with severe COVID-19 pneumonia

BACKGROUND: NK cells seem to be mainly involved in COVID-19 pneumonia. Little is known about NKT cells which represent a bridge between innate and adaptive immunity. METHODS: We characterized peripheral blood T, NK and NKT cells in 45 patients with COVID-19 pneumonia (COVID-19 subjects) and 19 healt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zingaropoli, Maria Antonella, Perri, Valentina, Pasculli, Patrizia, Cogliati Dezza, Francesco, Nijhawan, Parni, Savelloni, Giulia, La Torre, Giuseppe, D'Agostino, Claudia, Mengoni, Fabio, Lichtner, Miriam, Ciardi, Maria Rosa, Mastroianni, Claudio Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661928/ https://www.ncbi.nlm.nih.gov/pubmed/33189887 http://dx.doi.org/10.1016/j.clim.2020.108630

Ejemplares similares

Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2021)

Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients
por: Marocco, Raffaella, et al.
Publicado: (2022)

JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis
por: Ciardi, Maria Rosa, et al.
Publicado: (2020)

The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia
por: Ciardi, Maria Rosa, et al.
Publicado: (2020)

Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus
por: Tortellini, Eeva, et al.
Publicado: (2023)

1203. Systemic, Mucosal Immune Activation And Psycho-sexual Health in HIV-Infected And Uninfected Women: Evaluation of Biomarkers And Environmental Stimuli
por: Nijhawan, Parni, et al.
Publicado: (2020)

Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2023)

Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine
por: Dominelli, Federica, et al.
Publicado: (2022)

Systemic, Mucosal Immune Activation and Psycho-Sexual Health in ART-Suppressed Women Living with HIV: Evaluating Biomarkers and Environmental Stimuli
por: Nijhawan, Parni, et al.
Publicado: (2023)

Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study
por: Russo, Gianluca, et al.
Publicado: (2021)

Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease
por: Fedele, Giorgio, et al.
Publicado: (2022)

Evaluation of Immunogenicity to Three Doses of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Lung Transplant Patients
por: Guardiani, Mariasilvia, et al.
Publicado: (2022)

Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection
por: Vita, Serena, et al.
Publicado: (2020)

Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH
por: Tortellini, Eeva, et al.
Publicado: (2022)

Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2023)

Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2023)

Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19
por: Savelloni, Giulia, et al.
Publicado: (2022)

Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2022)

Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients
por: D’Abramo, Alessandra, et al.
Publicado: (2016)

Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection
por: Cogliati Dezza, F., et al.
Publicado: (2021)

Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2022)

Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
por: Salciccia, Stefano, et al.
Publicado: (2021)

Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis
por: D'Abramo, Alessandra, et al.
Publicado: (2014)

Longitudinal Virological and Immunological Profile in a Case of Human Monkeypox Infection
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2022)

Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients
por: Iannetta, Marco, et al.
Publicado: (2019)

Mesenchymal stem cells for subchondral bone marrow lesions: From bench to bedside
por: Pasculli, Rosa M., et al.
Publicado: (2022)

COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality
por: Petrella, Carla, et al.
Publicado: (2023)

Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation
por: Iannetta, Marco, et al.
Publicado: (2016)

Immunological diagnosis as an adjunctive tool for an early diagnosis of tuberculous meningitis of an immune competent child in a low tuberculosis endemic country: a case report
por: Vita, Serena, et al.
Publicado: (2017)

COVID-19 Severity and Androgen Receptor Polymorphism
por: Buonacquisto, Alessandra, et al.
Publicado: (2022)

Pharmacokinetics and Biodistribution of Rhopalurus junceus Scorpion Venom in Tumor-Bearing Mice after Intravenous and Oral Administration
por: Díaz-García, Alexis, et al.
Publicado: (2019)

Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience
por: Infantino, Maria, et al.
Publicado: (2022)

Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: A case report
por: Caraffa, Emanuela, et al.
Publicado: (2018)

JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus
por: Zingaropoli, Maria A., et al.
Publicado: (2018)

Tocilizumab effects in COVID-19 pneumonia: role of CT texture analysis in quantitative assessment of response to therapy
por: Masci, Giorgio Maria, et al.
Publicado: (2021)

Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
por: Scheidell, Joy D, et al.
Publicado: (2022)

Blood Biomarkers from the Emergency Department Disclose Severe Omicron COVID-19-Associated Outcomes
por: Pennacchia, Fiorenza, et al.
Publicado: (2023)

Application of machine learning approach in emergency department to support clinical decision making for SARS-CoV-2 infected patients
por: Casano, Nicolò, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year
por: Ramirez, Giuseppe A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0o82rm44jhagjh46hdqe7837hj